Sanofi SA (SAN.PA) — Quality & forensics
As of 2026-11-21 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 59
- Quality 69
- Growth 55
- Balance sheet 53
- Cash quality 50
- Capital allocation 89
- Momentum 77
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the SAN.PA chart & overview
FAQ · from the current data · as of 2026-11-21
Quick answers
What is Sanofi SA's Closelooknet quality reading?
The composite reads 63/100 across 7 modules, as of 2026-11-21: valuation 59, quality 69, growth 55, balance sheet 53, cash quality 50, capital allocation 89, momentum 77. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Sanofi SA's Altman Z-Score?
2.49, which sits in the grey zone (1.81–2.99) as of 2026-11-21. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Sanofi SA's Piotroski F-Score?
7 of 9, as of 2026-11-21. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Sanofi SA's Beneish M-Score indicate?
-2.58 — below the −1.78 manipulation-risk threshold, as of 2026-11-21. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ASML.AS ASML Holding N.V.
- TEMN.SW Temenos Group AG
- SGE.L Sage Group PLC
- WKL.AS Wolters Kluwer N.V.
- CEVI.ST CellaVision AB
- REL.L Relx PLC
- SECT-B.ST Sectra AB (publ)
- PATH Uipath Inc
- SAP.DE SAP SE
- OXIG.L Oxford Instruments PLC
- DSY.PA Dassault Systemes SE
- HEXA-B.ST Hexagon AB (publ)
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- NVO Novo Nordisk A/Sindustry
- AZN.L AstraZeneca PLCindustry
- GSK GSK plcindustry
- SNY Sanofi ADRindustry
- GILD Gilead Sciences Incindustry